Delivery Order SPE2DB24D2010-SPE2DB25FAAPL
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a $47,021.50 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of DESCOVY 200-25 mg tablets (30-unit packs). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of DESCOVY 200-25 MG tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $21,761.46 and is scheduled for completion by July 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $13,203.86 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) with an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The award represents a continuation of the company's role as a critical supplier within the federal medical supply chain, specifically...
- The Defense Logistics Agency awarded a $24,347.36 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, issued competitively under open procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. DESCOVY is an antiretroviral medication...
- The Defense Logistics Agency awarded a $44,543.69 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $14,991.82 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 29, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through full and open competition. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $29,898.04 for DESCOVY 200-25 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed price contract, executed without set-aside provisions, represents a competitively awarded procurement under the agency's pharmaceutical supply chain. The award is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, leveraging the...
- The Defense Logistics Agency awarded a delivery order valued at $24,376.15 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on July 22, 2025, with completion scheduled for July 23, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $5,662.17 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,072.97 for DESCOVY 200-25 mg tablets (30-count units) on July 28, 2025, with completion targeted for July 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAAPLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of DESCOVY 200-25 mg tablets (30-count units) with a ceiling value of $12,630.26. This competitively awarded, firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical supplier to the federal government, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key vendor within the DLA's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 7/30/25 |